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will be dreadfully misused. I also have
other concerns about the work. If I had I
been a reviewer, I would have considered
this paper publishable only ifthe language
and implications were modified.
Perhaps of greatest importance, this
paper does not create confidence in EHP
there seems to have been a lack ofdiligence
in the review of this manuscript. EHP
should be a flagship among journals, but
poor reviewing will set it adrift.
Frank N. Dost
Freeland, Washington
E-mail: jfdost@whidbey.com
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Response from Lieberman
and Colleagues
Several of the scientists who responded to
our paper (1) raised similar questions, most-
ly showing a concern about the high doses
used in our study. However, we would like
to point out that, to the best ofour knowl-
edge, our paper is the first to examine the
LD50 of cyclosiloxanes (CSs). While there
may be a difference of opinion about the
interpretation of these data, for the first
time there are data to discuss. Of equal
importance is that we provide data on doses
lower than the LD50. These data demon-
strate elevated serum enzyme values and
histopathologic changes following adminis-
tration of CSs and CS-D4 at nonlethal
doses (0.1 mL/mouse; - 3.5 g/kg). All of
these considerations underscore the value of
our work. Other studies have used similar
doses and the same route ofadministration
(0.1-lmL intraperitoneally) to examine the
toxicity of organic compounds including
siloxanes (2-4). In our studies, no effects
were noted when 1 mL soy oil was adminis-
tered as a control. Our studies were intend-
ed to examine the acute toxicity of these
agents rather than to evaluate their chronic
toxicity or to determine the minimal level at
which theyproduced a toxic effect.
Another concern raised by readers was
the comparison of cyclosiloxanes with car-
bon tetrachloride (CC14) and trichloroeth-
ylene. We included this discussion to darify
the fact that even though the LD50 for CS-
D4 is high (-7 g/kg), it falls in the range
of known toxic organic solvents such as
CC14 and trichloroethylene (2). Both CC14
and trichloroethylene have been used at
gram levels to study their acute toxicity by
intraperitoneal injection (2,5,6). Witschi
states that CC14 is moderately toxic and
trichloroethylene is relatively nontoxic.
However, the Agency for Toxic Substances
and Disease Registry (ATSDR) has pub-
lished profiles on the toxicity ofthese com-
pounds and the potential human exposure
and health hazards of these solvents (5,6).
In these documents they note that the max-
imum contaminant level (MCL) for each of
these compounds in drinking water is 5
jpg/L. Because CSs and these organic sol-
vents have similar LD50 values in the gram
per kilogram range, it is possible that after
thorough study of the toxicity of the CSs,
similar MCLs may be set. In addition,
trichloroethylene has been identified
among the top 20 hazardous materials on
the 1997 ATSDR priority list (ranked 15)
(7). This fact emphasizes that compounds
with LD values in this range are impor-
tant pubfic health concerns. Clearly there is
considerable variation in the verbal descrip-
tors ofthe toxicityofthese compounds.
The point is raised that CSs show about
the same acute toxicity as alcohol and sodi-
um chloride and that these chemicals are
freely available in most homes. The pre-
sumption is that, for this reason, we should
have minimal concern about the toxicity of
CSs. Yet we know that analysis of ethyl
alcohol and sodium chloride has led to the
opposite conclusion. Ethyl alcohol is an
important liver toxicant, and many people
worldwide suffer from liver disease as a
result of chronic ethyl alcohol ingestion.
Fetal alcohol syndrome is also well docu-
mented. As for sodium chloride, the rela-
tionship between ingestion ofhigh amounts
ofsalt and high blood pressure and stroke is
well known. We emphasized the need for
additional studies ofCSs in the concluding
two sentences ofour paper:
Further, our studies have not evaluated possible
long-term effects of CSs such as chronic inflam-
mation, chronic pulmonary and liver disease, or
neoplasia. Nevertheless, our results underscore
the importance ofa complete analysis ofthe toxi-
city ofCSs.
Witschi also suggests that the phrase
"cyclosiloxanes are widely distributed" is a
misinterpretation ofour data because only
0.1-0.5% is found in different organs (8).
The term "widely distributed" is used not
as an index ofthe abundance ofCSs in dif-
ferent organs but as a statement of their
presence. We would also like to point out
that we only measured unmetabolized CSs
in these studies. If these compounds were
modified by biotransformation and existed
as new, low-molecular species or bound to
macromolecules, we would not have
detected them by our analysis. Further,
most studies ofsiloxanes until recentlywere
carried out without any quantitative assess-
ment, that is, tissue level ofsiloxanes versus
tissue injury (9). In recognition of this
problem, our group has developed methods
for the detection and quantitation of
cyclosiloxanes in biological tissues (1J).
Carlton and Meeks raise the issue ofthe
preparation of the distillate and the fact
that the "cracking" process at 1800C has no
relationship to breakdown in the intact
implant in vivo. In our paper we made no
inferences about the relationship of distil-
late preparation to breakdown. Rather, we
used the distillation process as a convenient
way to produce a mixture of siloxanes,
which we found migrated out of intact
implants (11). We could have just as easily
purchased the components from a chemical
company, and in fact, that is what we did
with the octamethylcyclotetrasiloxane (CS-
D4). This purchased CS-D4 produced
effects that were indistinguishable from
those ofthe distillate.
Meeks also suggests that these mice
died ofinfection. First, ifthey had died of
infection, this would be an important find-
ing because only mice exposed to the distil-
late or CS-D4 died or developed evidence
of tissue injury. However, the histopatho-
logic picture is not one of infection. The
histopathology ofthe liver showed a classic
pattern of chemically induced cell death,
and the lung lesions were not typical of
bronchopneumonia or lobar pneumonia.
Meeks raises the question of metabo-
lism and clearance. He is accurate that we
do not cite any of the references he has
provided in our discussion. We were in
error in not including the contribution of
McKim et al. (12). The paper was pub-
lished in 1998 and we simply missed it.
All of the other references on CS-D4
metabolism that he cites are abstracts and
not full-length, peer-reviewed articles.
Meeks raises an important point. He
interprets his data to mean that CS-D4 is
metabolized and is rapidly cleared from
the body. While this may be true, never-
theless, many compounds are metabolized
via more than one metabolic pathway;
some of the pathways lead to detoxifica-
tion/inactivation and others lead to active
chemical species that cause tissue injury,
cell death, or neoplasia. The abundant lit-
erature on compounds such as aflatoxin,
benzo(a)pyrene, acetylaminoflurene, and
related compounds provide examples of
this principle. We would also like to point
out that the study Meeks refers to was an
inhalation study, which may not be direct-
ly relevant to our findings.
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We believe that much more work on
the low molecular weight cyclosiloxanes is
necessary. Inhalation studies like the one
referred to by Meeks, ingestion studies like
the one summarized by Lukasiak et al., and
injection studies are all necessary to develop
an understanding of the biologic impor-
tance ofthese agents.
We are confident that our paper repre-
sents an important contribution to the
study ofsilicone toxicology and hope that
it will encourage many additional studies
in this area.
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